proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke. (Q42710833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tomás Sobrino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Josune Orbe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

José Castillo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Eduardo Martínez-Vila

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

José A Paramo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

A Purroy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1464-1473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

2 March 2020

cites work

1 reference

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

Matrix metalloproteinases: fold and function of their catalytic domains

21 January 2018

1 reference

Matrix metalloproteinases in cerebrovascular disease

21 January 2018

1 reference

Multiple roles for MMPs and TIMPs in cerebral ischemia

21 January 2018

1 reference

Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke

21 January 2018

1 reference

A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke

21 January 2018

1 reference

Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.

21 January 2018

1 reference

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.

21 January 2018

1 reference

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

21 January 2018

1 reference

Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation

21 January 2018

1 reference

C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.

21 January 2018

1 reference

Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.

21 January 2018

1 reference

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

21 January 2018

1 reference

Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.

21 January 2018

1 reference

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier

21 January 2018

1 reference

Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review

21 January 2018

1 reference

Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice

21 January 2018

1 reference

Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside

21 January 2018

1 reference

Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study.

21 January 2018

1 reference

Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?

21 January 2018

1 reference

The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.

21 January 2018

1 reference

A role for tumor necrosis factor-α in ischemia and ischemic preconditioning

21 January 2018

1 reference

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.12312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742289%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference